Additionally, our findings of a lower mutation frequency in PIK3CA (15%) in TNBC, compared to its higher frequency in other BC subtypes (40.3%), suggest that distinct molecular mechanisms drive TNBC. This evidence concerns the gene PIK3CA and breast cancer.